Showing posts with the label 2025Show all
Natural compounds in prostate cancer therapy: In silico study
Abul Bashar Ripon Khalipha 1, 3 * Abu Bakar Siqqique 1 , Jewel Sheikh 1 , Md. Abdul Kader Shakil 2 , Shoaib Ahmed 1 , Khadija Akter 1 , Taslima Akter 4 1 De…
Read Full Article
OnnoRokom Group is a dynamic organization that actively supports innovative initiatives, including "International Journal of In-Silico Drug Design (IJISDD)". Their dedication to fostering technological and educational advancements has made them a prominent sponsor in the industry.
Learn more about them at OnnoRokom Group.
International Journal of In-Silico Drug Design (IJISDD) is a multidisciplinary platform at the intersection of computing, pharmacology, toxicology, and pharmaceutics. Focused on neuroscience, drug discovery, and multiscale modeling, it encourages deterministic and stochastic modeling of biological processes. Learn More...
Connect US